A dual-index framework for cold atmospheric plasma dosing: A meta-analysis of parametric control from volumetric redox flux to redox homeostatic status
Abstract
Cold atmospheric plasma (CAP) has emerged as a versatile therapeutic platform with demonstrated efficacy across diverse disease models. Despite significant preclinical progress, clinical translation remains hindered by the absence of standardized dosing protocols and consensus on dosimetric quantification. This systematic review and meta-analysis synthesizes evidence from 2020 to 2025 to establish a parametric framework for CAP dosing grounded in quantitative analysis of dose-dependent biological responses. We first characterize the biphasic, hormetic nature of CAP biological effects, demonstrating that moderate-to-high doses induce pro-oxidant cytotoxicity via oxidative stress-mediated cell death, whereas low-to-moderate doses activate antioxidant defense pathways favoring cytoprotection. Through systematic analysis of 400+ studies meeting inclusion criteria, we quantitatively map five critical control parameters, frequency, flow rate, voltage, processing time, and gas composition, elucidating their individual and synergistic influences on reactive species profiles and therapeutic outcomes. Our meta-analysis reveals distinct parametric distributions across discharge configurations, treatment modalities, and disease applications. Based on this quantitative synthesis, we propose a dual-index integrative framework for CAP dosage: volumetric reactive oxygen and nitrogen species flux as the physical dosimetric index governing parametric control, and redox homeostatic status as…
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- Learning from First-Generation Qualitative Approaches in the IS Discipline: An Evolutionary View and Some Implications for Authors and Evaluators (PART 1/2)
- Commentary on the clinical and preclinical dosage limits of interstitially administered magnetic fluids for therapeutic hyperthermia based on current practice and efficacy models
- Prosthesis: New Technological Opportunities and Innovative Biomedical Devices
- The history and future of neural modeling for cochlear implants
- Ryanodine receptors: waking up from refractoriness
- Novel Transgenic Rabbit Model Sheds Light on the Puzzling Role of Matrix Metalloproteinase-12 in Atherosclerosis
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.